Introduction {#S0001}
============

Linezolid and florfenicol are both important antimicrobial agents. Linezolid is approved in human medicine and usually used as a last resort antimicrobial agent to treat infections caused by methicillin-resistant *Staphylococcus aureus* (MRSA) and vancomycin-resistant enterococci (VRE).[@CIT0001] Florfenicol is approved exclusively for food-producing animals, where it is mainly used for the control of respiratory tract infections.[@CIT0002] However, the acquired cross-resistance to linezolid and florfenicol has emerged during the past decade.[@CIT0003]--[@CIT0005]

Currently, at least three different groups of acquired resistance genes which confer cross-resistance to linezolid and florfenicol have been identified. These include *cfr, optrA* and *poxtA*.[@CIT0003]--[@CIT0005] Among them, the *optrA* gene encodes a ribosomal protection protein of the ABC-F family.[@CIT0006] It was first found in *Enterococcus faecalis* and *Enterococcus faecium*,[@CIT0004] but has also been detected meanwhile in various Gram-positive bacteria.[@CIT0007],[@CIT0008]

In this study, two pheromone-responsive conjugative plasmids harboring *optrA* along with other resistance genes were analyzed to elucidate the basis for co-selection and dissemination. Furthermore, two novel mobile *optrA* loci in these plasmids were identified.

Materials and methods {#S0002}
=====================

Bacterial strains and antimicrobial susceptibility testing {#S0002-S2001}
----------------------------------------------------------

Two *optrA*-positive *E. faecalis* strains (E211--ST59 and E508--ST256) were identified from fecal samples of swine in Henan Province, China during a routine survey in 2015. Antimicrobial susceptibility testing was performed by broth microdilution according to the recommendations given in document M100 (28^th^ ed.) of the Clinical and Laboratory Standards Institute (CLSI).[@CIT0009] *S. aureus* ATCC 29213 served as the quality control strain.

PCR analysis {#S0002-S2002}
------------

The presence of the *optrA* gene was detected by PCR using the primers listed in [Table 1](#T0001){ref-type="table"}. The *optrA*-carrying plasmid pE349 was used as the positive control.[@CIT0004] The presence of the circular intermediate was detected by inverse PCR using the primers listed in [Table 1](#T0001){ref-type="table"}. All the PCR products were subjected to Sanger sequencing.Table 1PCR primers used in this studyCategory and genePrimer designationSequence (5ʹ-3ʹ)Product size(bp)Reference or source*optrAoptrA*-fwGCACCAGACCAATACGATACAA794This study*optrA*-rvTCCTTCTTAACCTTCTCCTTCTCA*optrA* minicircle in plasmid pE211circ-I-fwTATCAAGCGAAATATGCAGG4,052This studycirc-I-rvTGCACCATTTTAGCTTTCGT*bcr*ABDR minicirclecirc-II-fwAAATGGGTATGGGCAATATG4,633This studycirc-II-rvATCGCTTGTGGGCTATATCATn*558* minicirclecirc-III-fwCGGTGCCTAATCATTCGTATGC11circ-III-rvCGCTTAACCGGTTCTATCACTTCA*optrA* minicircle in plasmid pE508circ-IV-fwTGCACATACTTGAAACCTCC3,601This studycirc-IV-rvCTTGAACTACTGATTCTCGG*aac*(A)*-aph*(D) minicirclecirc-V-fwTGCCACACTATCATAACCACT3,227This studycirc-V-rvACTTTTAATTCTAGCGTGCCT

Transfer experiments {#S0002-S2003}
--------------------

To investigate the transferability of the *optrA* gene, these two *E. faecalis* strains were used in conjugation experiments with *E. faecalis* JH2-2 (rifampicin resistant) as the recipient.[@CIT0010] Transfer frequency is expressed as transconjugant per donor. Colonies that grew on the selective plates supplemented with 50 mg/L rifampin and 10 mg/L florfenicol after incubation for 16--24 h at 37°C were further confirmed by antimicrobial susceptibility testing and multilocus sequence typing (MLST) following harmonized protocols (<http://www.mlst.net/>).

Sequencing and analysis {#S0002-S2004}
-----------------------

Whole genome DNA of two *optrA*-positive transconjugants E211-T1 and E508-T1 was sequenced by the PacBio RS and Illumina MiSeq platforms. The sequences from PacBio sequencing reads were *de-novo* assembled and corrected by Illumina MiSeq with pilon. Glimmer 3.02 was used to predict open reading frames (ORFs) and the software blast was used to annotate those ORFs. The sequences determined had been deposited in GenBank under accession numbers MK425644 (pE211) and MK425645 (pE508), respectively.

Results and discussion {#S0003}
======================

The *optrA* gene in *E. faecalis* is transferable {#S0003-S2001}
-------------------------------------------------

The conjugation experiments indicated that these two *E. faecalis* strains (E211--ST59 and E508--ST256) could transfer florfenicol resistance to the recipient *E. faecalis* JH2-2 (ST8) at high transfer frequencies, of 2.6×10^−2^ for *E. faecalis* E211 and 3.7×10^−2^ for *E. faecalis* E508 (transconjugant per donor), respectively. Two transconjugants which were confirmed to share the same background with the recipient (ST8), designated E211-T1 and E508-T1, respectively, were selected for further studies. Sequencing and sequence analysis identified two conjugative *optrA*-carrying plasmids, designated pE211 and pE508, which were derived from E211-T1 and E508-T1, respectively. The conjugative transfer region in both plasmids pE211 and pE508 displayed the greatest similarity with that in plasmid pTW9, which has key conjugative properties of pheromone-responsive plasmids, such as aggregation substance (As). In combination with with their high transfer frequencies, these two plasmids (pE211 and pE508) can be classified as pheromone-responsive conjugative plasmids. MICs of the two *E. faecalis* strains, their transconjugants and the recipient strain are shown in [Table 2](#T0002){ref-type="table"}. After transfer, the transconjugants displayed elevated MICs to the respective antimicrobial agents, including florfenicol, linezolid and bacitracin in E211-T1, and florfenicol, linezolid, gentamicin and tetracycline in E508-T1. As shown in [Table 3](#T0003){ref-type="table"}, although there are few amino acid substitutions, the linezolid resistance that the OptrA variants in *E. faecalis* E211 or E508 confer remains the same with the OptrA prototype in *E. faecalis* E349.[@CIT0004]Table 2The antimicrobial susceptibilities of the wild-type strains, transconjugants, and recipient strains in this studyStrainsMICs(mg/L)^a^FFCLZDBACGENTETE2111288128\>128128E211-T1^b^128812881E50812884\>128128E508-T1^b^12882\>12864JH2-242281[^2] Table 3Comparison the difference of OptrA variants and MICs with wide-type strainStrainOptrA variantAmino acid substitutionsMICs of linezolid (mg/L)ReferencesE349Wide-typenone84E211EDK3**[E]{.ul}**, G393**[D]{.ul}**8This studyE508DPY176**[D]{.ul}**, T481**[P]{.ul}**8This study

Both plasmids pE211 and pE508 have a novel mobile *optrA* locus {#S0003-S2002}
---------------------------------------------------------------

The IS*1216*-flanked *optrA* locus in plasmid pE211 consisted of the transcriptional regulator gene *araC*, the *optrA* gene and a restriction endonuclease gene (MGE1 in [Figure 1A](#F0001){ref-type="fig"}, 12,834 bp), while that in plasmid pE508 carried the *optrA* gene and a truncated *erm*(A)-like gene (MGE3 in [Figure 1B](#F0001){ref-type="fig"}, 7,561 bp). In both plasmids, *optrA* was flanked by two copies of IS*1216* genes located in the same orientation, forming a novel locus, which was different from that described in previous studies ([Figure 2](#F0002){ref-type="fig"}).[@CIT0011],[@CIT0012] In both cases, the two IS*1216* elements can recombine and "loop out" a circular intermediate, which can then integrate either into plasmids or in the chromosomal DNA by recombination with another IS*1216* copy. Via this way, the *optrA* gene can move between different chromosomal and plasmidic locations. If finally integrated into a conjugative plasmid or ICE, it can move with this element across strain, species or even genus boundaries. To investigate whether circular intermediates were present, inverse PCR assays using the primers listed in [Table 1](#T0001){ref-type="table"} were conducted and the results showed that circular intermediates of different sizes (4,052 bp in plasmid pE211 and 3,601 bp in plasmid pE508) were formed in these strains. Sequence analysis of these circular intermediates confirmed that they contained one copy of the IS*1216* element and the sequence that was formerly located between the two IS*1216* elements, including *optrA*.Figure 1The structure of two pheromone-responsive conjugative multiresistant plasmids carrying a mobile *optrA* locus from *E. faecalis* in this study (**A**) The structure of the plasmid pE211. The positions of two mobile elements (MGE1 and MGE2), and Tn*558* were indicated in bold vertical lines and arrows outside the plasmid, (**B**) The structure of the plasmid pE508. The positions of two mobile elements (MGE3 and MGE4) were indicated in bold vertical lines and arrows outside the plasmid. The circles display (from the outside to inside): (i) the size scale in bp; (ii) the positions of predicted coding sequences transcribed in the clockwise orientation; (iii) the positions of predicted coding sequences transcribed in the counterclockwise orientation; (iv) the GC content plotted against 50%, with orange indicating \>50% and purple indicating \<50%; and (v) GC skew \[(G-C)/(G+C)\] in a 10,000 bp window. Genes are colour-coded, depending on functional annotations: blue, transposition; red, antimicrobial resistance; green, other function; gray, hypothetical protein.Figure 2The environment of the *optrA* gene in different plasmids.

The IS*1216*-like elements have also been reported to be associated with the vancomycin resistance *VanA gene* cluster in *E. faecium*,[@CIT0013] the multidrug resistance genes *poxtA, optrA* and *cfr* in enterococci and staphylococci,[@CIT0005],[@CIT0011],[@CIT0014] the macrolide-lincosamide-streptogramin B resistance genes *erm*(B) and *erm*(T) in enterococci and streptococci,[@CIT0015],[@CIT0016] and the tetracycline resistance gene *tet*(S) in *Streptococcus infantis*.[@CIT0017] These observations, along with multiple MGEs (MGE1-MGE4) associating with IS*1216* elements found in this study, suggest that the IS*1216*-like elements could play an important role in dissemination of the respective antimicrobial resistance genes among various Gram-positive organisms.

The analysis of the genetic context of *optrA* in plasmids pE211 and pE508 {#S0003-S2003}
--------------------------------------------------------------------------

As shown in [Figure 1A](#F0001){ref-type="fig"} and [Table 4](#T0004){ref-type="table"}, the 77,562 bp plasmid pE211 harbored the phenicol/oxazolidinone resistance gene *optrA*, the TN558- associated phenicol resistance gene *fexA*, and the mobile bacitracin resistance operon *bcr*ABDR (Mobile Genetic Element, MGE2, 5,527 bp). The *fexA*-carrying transposon Tn*558* has previously been described on plasmids in *Staphylococcus lentus, Staphylococcus cohnii*, and *Enterococcus* spp.[@CIT0011],[@CIT0018],[@CIT0019] Here, it is present on plasmid pE211 in *E. faecalis*. The MGE2 consisting of the *bcr*ABDR operon confers resistance to bacitracin. The *bcr* locus was flanked by IS*Enfa1* elements as previously described in *E. faecalis* or *Clostridium perfringens*.[@CIT0020],[@CIT0021] Here, it is present on the plasmid pE211 in *E. faecalis*.Table 4Coding sequences of the plasmid pE211CDS no.CDSNucleotide position (5ʹ→3ʹ)Protein length (aa)Database match (Size and accession no.)aa identify (%)1*repA*1--1008335replication initiator protein A, *Enterococcus faecalis* (335aa, WP_002382056.1)99.7% (334/335)2*orf*1358--2305315ATPase, *Enterococcus faecalis* (315aa, WP_025192929.1)99.7% (314/315)3*orf*4303--4971222CPBP family intramembrane metalloprotease, *Enterococcus faecalis* (222aa, WP_002403283.1)99.5% (221/222)4*orf*6038--6658206resolvase, N-terminal domain protein, *Enterococcus faecalis* (211aa, EFU10278.1)97.6% (206/211)5IS*1216*6830--7516232IS*6*-like element IS*1216* family transposase, *Enterococcus faecium* (232aa, WP_014748744.1)100.0% (232/232)6*fexA*8026--9453475aachloramphenicol/florfenicol efflux MFS transporter FexA, *Enterococcus faecalis* (475aa, WP_078122474.1)100.0% (475/475)7*orf138*9631--10,047138putative oxidoreductase, *Staphylococcus saprophyticus* (138aa, AVE17237.1)100.0% (138/138)8*tnpC*10,330--10,695121Transposase C, *Staphylococcus aureus* (121aa, YP_007878373.1)100.0% (121/121)9*tnpB*10,697--12,616639Transposase B, *Staphylococcus cohnii* (639aa, AEP69225.1)100.0% (639/639)10*tnpA*12,613--13,698361Transposase A, *Staphylococcus epidermidis* (361aa, AJW29167.1)100.0% (361/361)11*orf*15,103--15,726207resolvase helix-turn-helix protein, *Enterococcus faecium* (207aa, ADO66759.1)100.0% (207/207)12IS*1216E*17,617--18,297226IS*6*-like element IS*1216* family transposase, *Enterococcus faecium* (226aa, YP_006937527.1)100.0% (226/226)13*araC*18,886--20,040384AraC family transcriptional regulator, *Enterococcus faecalis* (384aa, AMM74624.1)100.0% (383/384)14*optrA*20,371--22,338655ABC-F type ribosomal protection protein OptrA, *Enterococcus faecalis* (655aa, WP_078122475.1)99.7% (653/655)15*orf*23,967--28,3671466restriction endonuclease, Enterococcaceae bacterium (1466aa, QBA99712.1)100.0% (1466/1466)16IS*1216E*29,642--30,322226IS*6*-like element IS*1216* family transposase, *Enterococcus faecium* (226aa, YP_006937527.1)100.0% (226/226)17*hp*30,735--31,376213Hypothetical protein, *Enterococcus faecalis* (213aa, AEF32577.1)100.0% (213/213)18*hp*31,758--33,086442Hypothetical protein, *Enterococcus faecalis* (442aa, AEF32578.1)99.8% (441/442)19*orf*33,195--34,076293DNA nuclease, *Enterococcus faecalis* (293aa, AEF32579.1)100.0% (293/293)20*hp*34,048--34,491147Hypothetical protein, *Enterococcus faecalis* (147aa, AEF32580.1)100.0% (147/147)21*hp*34,705--35,541278Hypothetical protein, *Enterococcus faecalis* (278aa, WP_127341853.1)99.6% (277/278)22*ssb*36,916--37,392158Single-strand binding protein, *Enterococcus faecalis* (158aa, NP_816947.1)100.0% (158/158)23*hp*37,532--38,872446Hypothetical protein, *Enterococcus faecalis* (446aa, WP_080008653.1)99.6% (444/446)24*hp*38,863--39,639258Hypothetical protein, *Enterococcus faecalis* (258aa, YP_004032980.1)100.0% (258/258)25*orf*47,434--49,998846Type VI secretion protein, *Enterococcus faecalis* (846aa, OIU90382.1)99.8% (844/846)26*orf*51,750--52,784344Conjugal transfer protein, *Enterococcus faecalis* (344aa, WP_002387763.1)100.0% (344/344)27*chap*54,111--55,382423CHAP domain-containing protein, *Enterococcus faecalis* (423aa, WP_010711028.1)100.0% (423/423)28*hp*56,288--57,166292Hypothetical protein, *Enterococcus faecalis* (292aa, NP_816968.1)100.0% (292/292)29*asa1*58,328--62,2181296aggregation substance, Enterococcaceae bacterium (1296aa, QBA99726.1)100.0% (1296/1296)30*orf*63,454--66,174906LPXTG-motif cell wall anchor domain protein, *Enterococcus faecalis* (906aa, EFM78589.1)100.0% (906/906)31*traA*68,199--69,158319Conjugal transfer protein TraA, *Enterococcus faecalis* (319aa, NP_816935.1)100.0% (319/319)32IS*Enfa1*69,902--70,582226IS*Enfa1* family transposase, *Staphylococcus aureus* (226aa, WP_000191454.1)100.0% (226/226)33*bcrD*70,779--71,609276Undecaprenyl-diphosphatase, *Enterococcus faecalis* (276aa, AOX48039.1)100.0% (276/276)34*bcrB*71,609--72,310249bacitracin ABC transporter permease, *Enterococcus faecalis* (249aa, WP_129343483.1)100.0% (249/249)35*bcrA*72,351--73,268305bacitracin ABC transporter, ATP-binding protein BcrA, *Enterococcus faecalis* (305aa, AQL55357.1)100.0% (305/305)36*bcrR*73,451--74,065204XRE family transcriptional regulator, *Enterococcus faecalis* (204aa, AXG90118.1)100.0% (204/204)37IS*Enfa1*74,621--75,301226IS*Enfa1* family transposase, *Staphylococcus aureus* (226aa, WP_000191454.1)100.0% (226/226)[^3]

As shown in [Figure 1B](#F0001){ref-type="fig"} and [Table 5](#T0005){ref-type="table"}, the 84,468 bp plasmid pE508 harbored the phenicol/oxazolidinone resistance gene *optrA*, the phenicol resistance gene *fexA*, the mobile bifunctional aminoglycoside resistance gene *aac*(A)-*aph*(D) locus (MGE4, 5,891 bp), and the tetracycline resistance genes *tet*(L) and *tet*(O/W/32/O). The aminoglycoside resistance gene *aac*(A)-*aph*(D) is usually located on the transposon Tn*4001* from staphylococci, Tn*5281* from enterococci or Tn*3706* from streptococci. Together with other resistance genes, it can also be located on the transposons Tn*924*, Tn*5384* or Tn*5385* from *E. faecalis*.[@CIT0022] In this study, to the best of our knowledge, it was for the first time seen that *aac*(A)-*aph*(D) is flanked by two copies of IS*1216* elements located in the same orientation on the plasmid pE508 from *E. faecalis*.Table 5Coding sequences of plasmid pE508CDS no.CDSNucleotide position (5ʹ→3ʹ)Protein length (aa)Database match (Size and accession no.)aa identify (%)1*hp*140--1600486Hypothetical protein, *Enterococcus faecalis* (486aa, WP_126254905.1)100.0%(486/486)2*hp*3025--3753242Hypothetical protein, *Enterococcus faecalis* (242aa, WP_126266300.1)100.0% (242/242)3*orf*10,688--11,188166DnaJ domain-containing protein, partial, *Enterococcus faecalis* (173aa, EOH11044.1)95.4% (165/173)4*orf*12,574--13,359261ArsR family transcriptional regulator, *Enterococcus faecalis* (261aa, WP_002387611.1)100.0% (261/261)5*hp*14,217--16,430737hypothetical protein, *Enterococcus faecalis* (737aa, ETJ10394.1)99.3% (732/737)6*hp*16,417--18,579*720*hypothetical protein, *Enterococcus faecalis* (720aa, WP_087548822.1)100.0% (720/720)7*orf*19,135--21,627830type VI secretion protein, *Enterococcus faecalis* (846aa, OIU90382.1)98.1% (830/846)8*orf*23,001--24,035344conjugal transfer protein, *Enterococcus faecalis* (344aa, WP_010774162.1)99.7% (343/344)9*hp*24,742--25,359205Hypothetical protein, *Enterococcus faecalis* (205aa, WP_033786897.1)99.5% (204/205)10*chap*25,362--26,633423CHAP domain protein, *Enterococcus faecalis* (423aa, EFU06796.1)100.0% (423/423)11*hp*27,539--28,417292Hypothetical protein, *Enterococcus faecalis* (292aa, WP_002405612.1)100.0% (292/292)12*prgB*29,580--33,4971305LPXTG cell wall anchor domain-containing protein, *Enterococcus faecalis* (1305aa, WP_010819058.1)99.6% (1300/1305)13*seal*34,280--37,003907Surface exclusion protein, Enterococcaceae bacterium (907aa, QBA99747.1)100.0% (907/907)14*traC*39,968--41,557529TraC protein, *Enterococcus faecalis* (529aa, EOK37046.1)99.4% (526/529)15*traB*41,607--42,764385TraB/GumN family protein, *Enterococcus faecalis* (385aa, WP_010717212.1)100.0% (385/385)16*repA2*42,934--43,944336replication initiator protein A, *Enterococcus faecalis* (336aa, WP_010774283.1)100.0% (336/336)17*parA*44,553--45,335260ParA family protein, *Enterococcus faecalis* (260aa, WP_010783395.1)100.0% (260/260)18*orf*46,984--48,300438Y-family DNA polymerase, *Enterococcus faecalis* (438aa, WP_126262290.1)100.0% (438/438)19*hp*48,617--50,647669Hypothetical protein, *Enterococcus faecalis* (669aa, WP_010829996.1)99.2% (664/669)20IS*1216*52,601--53,287228IS*1216* family transposase, *Enterococcus faecalis*(228aa, WP_080114306.1)100.0% (228/228)21IS*256*53,912--55,084390IS*256* transposase, *Staphylococcus aureus* (390aa, CAL22896.1)99.7% (389/390)22*aac*(A)*-aph*(D)55,214--56,653479bifunctional aminoglycoside N-acetyltransferase/aminoglycoside phosphotransferase, *Staphylococcus cohnii* plasmid (479aa, YP_009090128.1)100.0% (479/479)23IS*1216*57,683--58,369228IS*1216* family transposase, *Enterococcus faecalis*(228aa, WP_080114306.1)100.0% (228/228)24*fexA*60,449--61,876475Florfenicol/chloramphenicol exporter, *Staphylococcus lentus* (475aa, WP_032495681.1)99.8% (474/475)25*hp*63,385--63,990201Hypothetical protein, *Enterococcus faecalis* (201aa, OXC92628.1)100.0% (201/201)26*hp*65,562--66,395277GIY-YIG nuclease family protein, *Lactococcus lactis* (277aa, WP_060416607.1)99.6% (276/277)27*repA*68,095--69,273392Replication initiator protein, *Enterococcaceae bacterium* (392aa, QBA99761.1)100.0% (392/392)28IS*1216*70,722--71,408228IS*1216* family transposase, *Enterococcus faecalis* (228aa, WP_080114306.1)100.0% (228/228)29*tet*(L)71,967--73,343458tetracycline efflux MFS transporter Tet(L), *Streptococcus uberis* (458aa, WP_037627686.1)99.8% (457/458)30*tet*(O/W/32/O)74,006--75,925639tetracycline resistance ribosomal protection protein, *Streptococcus suis* (639aa, RRN51891.1)100.0% (639/639)31IS*1216*76,939--77,619228IS*6*-like element IS*1216* family transposase, *Enterococcus faecalis*(228aa, WP_080114306.1)100.0% (228/228)32*optrA*78,123--80,090655ABC-F type ribosomal protection protein OptrA, *Lactobacillales* (655aa, WP_099809080.1)99.8% (654/655)33*erm*(A)-like81,507--82,23824223S rRNA (adenine(2058)-N(6))-methyltransferase Erm(A), *Lactobacillus salivarius*(242aa, WP_086201761.1)100.0% (242/242)34IS*1216*83,691--84,377228IS*6*-like element IS*1216* family transposase, *Enterococcus faecalis*(228aa, WP_080114306.1)100.0% (228/228)[^4]

The presence of the circular intermediates in MGE2 and MGE4 were detected by inverse PCR ([Table 2](#T0002){ref-type="table"}) and further sequence analysis indicated that both MGEs are active. However, the Tn*558* locus is apparently not active as no circular intermediates were detectable.

Conclusion {#S0004}
==========

Two pheromone-responsive conjugative multiresistance plasmids carrying the novel *optrA* locus from *E. faecalis* were identified, with one plasmid (pE211) harbouring a mobile *bcr*ABDR locus, and the other (pE508) a mobile *aac*(A)-*aph*(D) locus. All these mobile locus were active due to the presence of the minicircles. The presence of MGEs in these plasmids renders them flexible and these elements will aid to the persistence and dissemination of these plasmids among enterococci and potentially also other Gram-positive bacteria.
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